addiction medicine

Addiction Medicine

Supporting Addiction Medicine Physicians and their Patients

Are you missing 10% to 15%* of your Patients' Positive Opioid Test Results?
You may be without High Sensitivity Definitive Testing.

Buprenorphine Reportable Limit: 1 ng/mL
Norbuprenorphine Reportable Limit: 5 ng/mL
Naloxone Reportable Limit: 5 ng/mL
Naltrexone Reportable Limit: 5 ng/mL

Emerging Drugs of Abuse

New and Emerging Drugs of Abuse, both illicit drugs and prescription medications, continuously enter the market causing demand for larger test panels to ensure patient recovery compliance. Synthetic Cannabinoids are a much more common drug of abuse today, in part caused by the ease of access to these illicit drugs. It is important to test for all potential drugs of abuse ensuring a patient’s safety and compliance during the critical early stages of recovery. LabSource recognizes and meets physicians' needs for current and highly accurate comprehensive toxicology testing results, along with meeting the need for rapid turn-around times for Addiction Medicine, Medication Assisted Therapy, and Intensive Outpatient Programs.

  • Bath Salts
    Common Names: Cloud 9, White Lightning, and Ivory Wave, Flakka (also called gravel or flocka)
  • Emerging Drugs
    Common Names: N-Bomb, Kratom, and Krokodil
  • Synthetic Cannabinoids
    Common Names: K2 and Spice

LabSource continually monitors the pulse of drug abuse trends to keep pace with the emerging drugs of abuse market. Synthetic designer drugs, like synthetic cannabinoids, cathinones, and phenethylamines, have grown in popularity based on the addictive properties and ease of access to these drugs. Testing for these drugs of abuse can ensure addiction recovery patients are remaining compliant with their treatment.

Extensive Drugs of Abuse Testing

Urine Drug Testing is an integral part of addiction medicine recovery by providing definitive evidence of patient compliance while removing the doubts of potential diversion. Definitive drug testing gives providers the resources to make patients accountable and can help enforce program compliance which supports better patient outcomes. Confirmatory testing using LC-MS/MS technology provides definitive patient testing results that are not found using Immunoassay Analyzer testing or Point-of-Care cups.

Meeting the Needs of Addiction Recovery Physicians with High Sensitivity Definitive Testing:

  • Extensive Panel of Prescription & Illicit Drugs of Abuse
  • Norbuprenorphine Testing to Identify Urine Spiking
  • Buprenorphine Cut-off 1 ng/ml – Confirm Patients Using Lower Doses
  • Norbuprenorphine Cut-off 5 ng/ml
  • Naloxone Cut-off 5 ng/ml
  • Continuous Profile Updates with New & Emerging Drugs of Abuse
  • Scientist Support for Results Review
  • Urine Drug Testing & Saliva Drug Testing

Benefits of Comprehensive Urine Drug Testing for Medication Monitoring / Risk Assessment

Improved Quality Care

  • Increase evidence of compliance and peace of mind for provider
  • Minimize risk of ADRs for patient, decrease overdoses and deaths
  • Increased diagnosis and treatment of addiction
  • Increased identification of self-medication, potentially leading to diagnosis and treatment of underlying psychological disease

Societal reasons: decrease drug diversion

  • Reduce criminal subculture
  • Decrease risk of addiction of others obtaining drugs illegally

*Internal LabSource testing data using High Sensitivity Definitive Testing Methodology

The LabSource Difference...

High Sensitivity Definitive Toxicology Testing

STAT Accounts Receive Expedited High Sensitivity Definitive Toxicology Testing Results.

30 Day Account Integration – LabSource Quickly Communicates Issues That Can Affect Testing and Turn-Around Time.

High Sensitivity Enzymatic Specimen Incubation Converts All Drugs and Metabolites to a Free-Detectable Form.

Solid Phase Extraction & Concentrate Eliminates Interferences and Extracts Drugs to Increase Sensitivity. Evaporates Liquid Leaving High Concentrations of Drugs for Maximum Sensitivity.

Proprietary Software Verifies Accuracy of All Detected Drugs with Results Reviewed by Two Certifying Scientists.

Patient Results are Compared to the Patient’s Previous Results.

Multi-Level Verification Process for Positive Non-Prescribed Medications.

Automatic Re-test and Verification of Unexpected Results; We Re-test 10% of Specimens.

contact us

Ask About Our Clinical Toxicology Testing Services

   call now   LabSource Phone   (877) 930-3390